Summary - XAIR - NASDAQ - Weiss Ratings

E

Beyond Air, Inc. XAIR

$1.62 -$0.15-8.48% NASDAQ

Recommendation

Prev Close

Volume

Avg Vol (90D)

Market Cap

Dividend & Yield

--

52-Week Range

$0.67 - $10.40

P/E (TTM)

--

EPS (TTM)

My Lists My Alerts

HealthTech & Bioinformatics Biotechnology Health Care Pharmaceutical

Access our Premium Ratings

Get Access

Rating

Reward

Risk

Rating Factors

Growth Index

Efficiency Index

Solvency Index

Total Return Index

Volatility Index

Dividend Index

Headlines

D. Boral Capital Reiterates Buy Rating for Beyond Air (NASDAQ:XAIR)

1/21/2026 - Ticker Report

Beyond Air (XAIR) Analyst Rating Maintained as Buy at $11.00 by D. Boral Capital XAIR Stock News

1/21/2026 - GuruFocus

Beyond Air initiated with bullish view at Rodman & Renshaw

1/20/2026 - The Fly

Beyond Air initiated with bullish view at Rodman & Renshaw

1/20/2026 - The Fly

Beyond Air initiated with bullish view at Rodman & Renshaw

1/20/2026 - The Fly

Beyond Air, Inc. (NASDAQ:XAIR) Short Interest Update

1/20/2026 - Ticker Report

Beyond Air (XAIR) Secures $5M Through Private Placement Deal

1/14/2026 - GuruFocus

Beyond Air Announces $5.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules

1/14/2026 - GuruFocus

Beyond Air prices 3.93M shares at $1.272 in private placement

1/14/2026 - The Fly

Beyond Air Announces $5.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules

1/14/2026 - Globe Newswire

XAIR Stock More Than Doubled Today What's Driving The Rally?

1/13/2026 - Stocktwits News Feed

Beyond Air, Inc. Shares Surge 166% On NeuroNOS Transaction

1/13/2026 - RTT News - Momentum Stocks

Promising Pharmaceutical Stocks To Add to Your Watchlist - January 13th

1/13/2026 - MarketBeat

Medical Stocks To Watch Now - January 13th

1/13/2026 - MarketBeat

XTL Biopharmaceuticals Acquires 85% of NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership

1/13/2026 - Globe Newswire

XTL Biopharmaceuticals To Acquire 85% Stake In NeuroNOS Ltd For $32.5 Mln

1/13/2026 - Nasdaq News: Markets

XTL Biopharmaceuticals Acquires 85% of Beyond Air's Subsidiary NeuroNOS, Entering the Massive ...

1/13/2026 - GuruFocus

Beyond Air (XAIR) Moves NeuroNOS to XTL Biopharmaceuticals Through Acquisition Deal

1/13/2026 - GuruFocus

XTL Biopharmaceuticals to acquire 85% of Beyond Air's NeuroNOS for $32.5M

1/13/2026 - The Fly

XTL Biopharmaceuticals Acquires 85% of Beyond Air's Subsidiary NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership

1/13/2026 - Globe Newswire

Beyond Air (XAIR) Names New CFO, Stock Rises

12/30/2025 - GuruFocus

Beyond Air Names Dan Moorhead CFO

12/30/2025 - Nasdaq News: Markets

Beyond Air appoints Dan Moorhead as CFO

12/30/2025 - TipRanks Financial Blog

Beyond Air appoints Dan Moorhead as CFO

12/30/2025 - The Fly

Beyond Air appoints Dan Moorhead as CFO

12/30/2025 - Seeking Alpha - Healthcare

Income Statement

Total Revenue (TTM)

EBITDA (TTM)

EBIT (TTM)

Net Income (TTM)

Balance Sheet

Total Assets (Q)

Total Debt (Q)

Total Liabilities (Q)

Book Value Per Share (Q)

Cash Flow

Cash from Operations (TTM)

Cash from Investing (TTM)

Cash from Financing (TTM)

Net Change in Cash (TTM)

Filings

Filing Date

Monday, November 10, 2025

Period Date

Tuesday, September 30, 2025

Next Filing

Week of Feb 9 and 13 (est)

Price History

Loading...

Beta

7-Day Total Return

30-Day Total Return

60-Day Total Return

90-Day Total Return

Year to Date Total Return

1-Year Total Return

2-Year Total Return

3-Year Total Return

5-Year Total Return

52-week Low

Dec 29, 2025 - $0.67

52-week High

Feb 11, 2025 - $10.40

Valuation

Market Cap

$13.83M - Nano Cap

Enterprise Value

Price/Sales (TTM)

Price/Book (Q)

Dividends and Shares

Shares Outstanding

Dividend Per Share (Most Recent)

--

Dividend Per Share (TTM)

--

Corporate Info

Website

www.beyondair.net

Phone Number

516 665 8200

Address

900 Stewart Avenue
Garden City, NY 11530

Country

Year Founded

Business Description

Sector

Industry

Health Care Equipment and Services

Beyond Air, Inc., a commercial-stage medical device and biopharmaceutical company, develops the Lungfit platform, a nitric oxide (NO) generator and delivery system platform. It operates through... more